Meta-Analysis of Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes and All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus.
about
Effects of Six Kinds of Sodium-Glucose Cotransporter 2 Inhibitors on Metabolic Parameters, and Summarized Effect and Its Correlations With Baseline DataEffects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on blood pressure and markers of arterial stiffness in patients with type 2 diabetes mellitus: a post hoc analysisCanagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy.The effect of SGLT2 inhibitors on cardiovascular events and renal function.A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus.Cardiovascular disease prevention strategies for type 2 diabetes mellitus.Sodium-glucose cotransporter 2 inhibitors and death and heart failure in type 2 diabetes.Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus.Cardiovascular Safety, Long-Term Noncardiovascular Safety, and Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis With Trial Sequential Analysis.Comorbidities in Heart Failure.Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors.Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials.Canagliflozin and Cardiovascular disease- results of the CANVAS trialComparison of Oral Antidiabetic Drugs as Add-On Treatments in Patients with Type 2 Diabetes Uncontrolled on Metformin: A Network Meta-Analysis
P2860
Q33763316-F1C176AF-E708-45EA-BA41-37B71ECAFDB2Q37668253-2ADDA9AD-2BD5-47EA-8FB6-C74892B1FA62Q37712199-15F6F288-84E1-4C84-8B30-748E084E32CEQ38614488-4B20A3B2-14DD-43B1-A1B3-36FBF9887E8CQ39255188-1111E66A-3A8E-4D91-93E8-5554AD28CD54Q39420208-DD3492A2-ED5B-405A-9B62-8208C512CF0EQ47109331-41FC89DC-9AA0-4734-B6F1-ADFBC56A2372Q47137994-35B5FBF4-9475-47B2-A1CC-EE53105ECA75Q47652080-BA4B4C8F-CA76-494D-8334-7E618C535A93Q47744924-FB1DCB72-AD8E-4565-AAF4-203D6D70F6A7Q55053753-87786663-5ADF-4391-AAC9-02D0F26AFD70Q55235411-5FAB1696-7307-490E-AF5E-2C7A30B9815DQ57814887-C4C9B90E-4352-422A-99FF-1DB692905A63Q58766494-1E0E40F1-3FF6-4EF0-8DF0-9FA718249F81
P2860
Meta-Analysis of Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes and All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus.
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@ast
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@en
type
label
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@ast
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@en
prefLabel
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@ast
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@en
P2093
P1476
Meta-Analysis of Effects of So ...... With Type 2 Diabetes Mellitus.
@en
P2093
Huilin Tang
Suodi Zhai
Tiansheng Wang
Yiqing Song
Zhenwei Fang
P304
P356
10.1016/J.AMJCARD.2016.08.061
P407
P577
2016-08-31T00:00:00Z